Hyderabad: Contract research organization GVK Biosciences Pvt. Ltd on Thursday said it has signed an agreement to acquire Chennai-based Vanta Bioscience Pvt. Ltd. The terms of the deal weren’t disclosed.

Vanta Bioscience offers toxicology evaluation services, complying with different regulatory guidelines for pharmaceutical, biotech, food supplements and feed additives industries. It also offers toxicology services using alternative methods for the cosmetics industry.

“The acquisition is in line with our business strategy of being an integrated drug discovery services provider for our customers," Manni Kantipudi, chief executive officer of GVK Biosciences, said in a statement. “We are constantly investing in upgrading our capabilities to provide world-class R&D services. Vanta Bioscience further advances our position as we expand our service offering in GLP (good laboratory practices) toxicology."

Vanta Bioscience has a state-of-the-art facility in Gummidipundi in Tamil Nadu and employs GLP-trained scientists with expertise in study design and execution of regulatory directed studies leading to investigational new drug filings, the company said.

“We are delighted to transition into an organization that can expand our offerings and provide further opportunities to our clients and staff," Gerard Schwickerath, vice president and general manager of Vanta Bioscience, said in the statement.

GVK Biosciences had in January acquired US-based Aragen Bioscience Inc. for an undisclosed sum.

Close